MAP3K7 and malignant colon neoplasm: They further identified JUN-terminal kinase (JNK)/MAPK8 or TAK1/MAP3K7 as transducing the signal from ERN1 to JUN; the simultaneous inhibition of this pathway and MEK results in synthetic lethality in KRAS-mutant human colon cancer cells.